Search
for
Sort by
Research 391–420 of 1000+
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- Tracing the cellular origin of cancer
- Epigenetics of Colorectal Cancer
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Risk factors for prostate cancer: a case-control study in Greece
- Cutaneous toxicities of cancer therapy
- Pegylated Liposomal Doxorubicin in the Treatment of Breast Cancer
- Selenium for preventing cancer
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
- New agents for cancer chemoprevention
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Nonmelanoma skin cancer treated with electronic brachytherapy: Results at 1 year
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- A Case-Control Study of Dietary Phytoestrogens and Testicular Cancer Risk
- Frequent downregulation of DMBT1 and galectin‐3 in epithelial skin cancer
- Biophysical basis of skin cancer margin assessment using Raman spectroscopy
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Efficacy and Skin Toxicity Management with Cetuximab in Metastatic Colorectal Cancer: Outcomes from an Oncologic/Dermatologic Cooperation
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer
- Redefining hormone resistance in prostate cancer